GTCR Announces Divestiture of Corza Medical's Biosurgery Business Unit to EQT
The transaction positions Corza's Biosurgery business for its next phase of growth, while Corza Medical continues to invest across its surgical technology businesses in Wound Closure, Ophthalmology and Biomedical Textiles. CHICAGO and BOULDER, Colo., July 7, 2026 /PRNewswire/ -- GTCR, a...
The transaction positions Corza's Biosurgery business for its next phase of growth, while Corza Medical continues to invest across its surgical technology businesses in Wound Closure, Ophthalmology and Biomedical Textiles. CHICAGO and BOULDER, Colo., July 7, 2026 /PRNewswire/ -- GTCR, a...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.